Skip to main content
SpringerLink
Log in

Large Asymptomatic FIGO Type 3–5 Fibroid and Primary Infertility

  • Chapter
  • First Online:
Uterine Fibroids

  • 869 Accesses

Abstract

The patient is a 30-year-old healthy nulligravid patient diagnosed with an 8 centimeter (cm) intramural fibroid (FIGO type 3–5) [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;(95):2204–8, 2208.e1–3.

    Google Scholar 

  2. Galen DI, Pemueller RR, Leal JG, Abbott KR, Falls JL, Macer J. Laparoscopic radiofrequency fibroid ablation: phase II and phase III results. JSLS. 2014;18:182–90.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol. 2014;26:151–61.

    Article  PubMed  PubMed Central  Google Scholar 

  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112:387–400.

    Article  Google Scholar 

  5. Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod. 2001;16:2411–7.

    Article  CAS  PubMed  Google Scholar 

  6. Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril. 1998;70:687–91.

    Article  CAS  PubMed  Google Scholar 

  7. Surrey ES, Lietz AK, Schoolcraft WB. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril. 2001;75:405–10.

    Article  CAS  PubMed  Google Scholar 

  8. Khalaf Y, Ross C, El-Toukhy T, Hart R, Seed P, Braude P. The effect of small intramural uterine fibroids on the cumulative outcome of assisted conception. Hum Reprod. 2006;21:2640–4.

    Article  CAS  PubMed  Google Scholar 

  9. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91:1215–23.

    Article  PubMed  Google Scholar 

  10. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010;25:418–29.

    Article  PubMed  Google Scholar 

  11. Oliveira FG, Abdelmassih VG, Diamond MP, Dozortsev D, Melo NR, Abdelmassih R. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril. 2004;81:582–7.

    Article  PubMed  Google Scholar 

  12. Somigliana E, De Benedictis SD, Vercellini P, Nicolosi AE, Benaglia L, Scarduelli C, et al. Fibroids not encroaching the endometrial cavity and IVF success rate: a prospective study. Hum Reprod. 2011;26:834–9.

    Article  PubMed  Google Scholar 

  13. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198:357–66.

    Article  PubMed  Google Scholar 

  14. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. Obstet Gynecol Clin N Am. 2006;33:153–69.

    Article  Google Scholar 

  15. Rosati P, Exacoustòs C, Mancuso S. Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study. J Ultrasound Med. 1992;11:511–5.

    Article  CAS  PubMed  Google Scholar 

  16. Shavell VI, Thakur M, Sawant A, Kruger ML, Jones TB, Singh M, et al. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril. 2012;97:107–10.

    Article  PubMed  Google Scholar 

  17. Bulman JC, Ascher SM, Spies JB. Current concepts in uterine fibroid embolization. Radiographics. 2012;32:1735–50.

    Article  PubMed  Google Scholar 

  18. Payne JF, Haney AF. Serious complications of uterine artery embolization for conservative treatment of fibroids. Fertil Steril. 2003;79:128–31.

    Article  PubMed  Google Scholar 

  19. Tropeano G, Litwicka K, Di Stasi C, Romano D, Mancuso S. Permanent amenorrhea associated with endometrial atrophy after uterine artery embolization for symptomatic uterine fibroids. Fertil Steril. 2003;79:132–5.

    Article  PubMed  Google Scholar 

  20. Pelage JP, Le Dref O, Soyer P, Kardache M, Dahan H, Abitbol M, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215:428–31.

    Article  CAS  PubMed  Google Scholar 

  21. Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005.

    Article  CAS  PubMed  Google Scholar 

  22. Goldberg J, Pereira L, Berghella V, Diamond J, Daraï E, Seinera P, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191:18–21.

    Article  PubMed  Google Scholar 

  23. Walker WJ, McDowell SJ. Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol. 2006;195:1266–71.

    Article  PubMed  Google Scholar 

  24. Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L, Ontario UFE Collaborative Group. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105:67–76.

    Article  PubMed  Google Scholar 

  25. Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 2006;108:49–54.

    Article  CAS  PubMed  Google Scholar 

  26. Kim YS, Kim JH, Rhim H, Lim HK, Keserci B, Bae DS, et al. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes. Radiology. 2012;263:600–9.

    Article  PubMed  Google Scholar 

  27. Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199–209.

    Article  PubMed  Google Scholar 

  28. Vilos GA, Daly LJ, Tse BM. Pregnancy outcome after laparoscopic electromyolysis. J Am Assoc Gynecol Laparosc. 1998;5:289–92.

    Article  CAS  PubMed  Google Scholar 

  29. Berman JM, Bolnick JM, Pemueller RR, Garza Leal JG. Reproductive outcomes in women following radiofrequency volumetric thermal ablation of symptomatic fibroids. A retrospective case series analysis. J Reprod Med. 2015;60:194–8.

    PubMed  Google Scholar 

  30. Jasonni VM, D’Anna R, Mancuso A, Caruso C, Corrado F, Leonardi I. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy. Acta Obstet Gynecol Scand. 2001;80:956–8.

    Article  CAS  PubMed  Google Scholar 

  31. Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol. 2004;16:239–43.

    Article  PubMed  Google Scholar 

  32. United States Food and Drug Administration. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019943s032,020011s039lbl.pdf. Revised June 2011. Accessed 7 June 2016.

  33. Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol. 2011;1:303–9.

    Article  Google Scholar 

  34. Lewis EI, Gargiulo AR. The role of Hysteroscopic and robot-assisted laparoscopic myomectomy in the setting of infertility. Clin Obstet Gynecol. 2016;59:53–65.

    Article  PubMed  Google Scholar 

  35. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;(2):CD000547.

    Google Scholar 

  36. Bulletti C, Polli V, Negrini V, Giacomucci E, Flamigni C. Adhesion formation after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1996;3:533–6.

    Article  CAS  PubMed  Google Scholar 

  37. Pundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20:335–45.

    Article  PubMed  Google Scholar 

  38. Gunnala V, Setton R, Pereira N, Huang JQ. Robot-assisted myomectomy for large uterine myomas: a single center experience. Minim Invasive Surg. 2016;2016:4905292.

    PubMed  PubMed Central  Google Scholar 

  39. Advincula AP, Xu X, Goudeau ST, Ransom SB. Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs. J Minim Invasive Gynecol. 2007;14:698–705.

    Article  PubMed  Google Scholar 

  40. Barakat E, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted laparoscopic and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117:256–65.

    Article  PubMed  Google Scholar 

  41. Liu G, Zolis L, Kung R, Melchior M, Singh S, Cook EF. The laparoscopic myomectomy: a survey of Canadian gynaecologists. J Obstet Gynaecol Can. 2010;32:139–48.

    Article  PubMed  Google Scholar 

  42. Oduyebo T, Hinchcliff E, Meserve EE, Seidman MA, Quade BJ, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG. Risk factors for occult uterine sarcoma among women undergoing minimally invasive gynecologic surgery. J Minim Invasive Gynecol. 2016;23:34–9.

    Article  PubMed  Google Scholar 

  43. Raine-Bennett T, Tucker LY, Zaritsky E, Littell RD, Palen T, Neugebauer R, et al. Occult uterine sarcoma and Leiomyosarcoma: incidence of and survival associated with Morcellation. Obstet Gynecol. 2016;127:29–39.

    Article  PubMed  Google Scholar 

  44. Pritts EA, Parker WH, Brown J, Olive DL. Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review. J Minim Invasive Gynecol. 2015;22:26–33.

    Article  PubMed  Google Scholar 

  45. U.S. Food and Drug Administration. UPDATED Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm. Updated 24 Nov 2014. Accessed 7 June 2016.

  46. Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg. 2015;12:165–77.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Harris JA, Swenson CW, Uppal S, Kamdar N, Mahnert N, As-Sanie S, et al. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. Am J Obstet Gynecol. 2016;214:98.e1–98.e13.

    Article  Google Scholar 

  48. Siedhoff MT, Wheeler SB, Rutstein SE, Geller EJ, Doll KM, Wu JM, et al. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis. Am J Obstet Gynecol. 2015;212:591.e1–8.

    Article  Google Scholar 

  49. Vargas MV, Cohen SL, Fuchs-Weizman N, Wang KC, Manoucheri E, Vitonis AF, et al. Open power morcellation versus contained power morcellation within an insufflated isolation bag: comparison of perioperative outcomes. J Minim Invasive Gynecol. 2015;22:433–8.

    Article  PubMed  Google Scholar 

  50. Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA, et al. Contained power morcellation within an insufflated isolation bag. Obstet Gynecol. 2014;124:491–7.

    Article  PubMed  Google Scholar 

  51. Choussein S, Srouji SS, Farland LV, Gargiulo AR. Flexible carbon dioxide laser fiber versus ultrasonic scalpel in robot-assisted laparoscopic myomectomy. J Minim Invasive Gynecol. 2015;22:1183–90.

    Article  PubMed  Google Scholar 

  52. Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod. 2013;28:99–108.

    Article  PubMed  Google Scholar 

  53. Parker WH, Einarsson J, Istre O, Dubuisson JB. Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol. 2010;17:551–4.

    Article  PubMed  Google Scholar 

  54. Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010;25:2475–9.

    Article  CAS  PubMed  Google Scholar 

  55. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005;95:57–62.

    Article  CAS  PubMed  Google Scholar 

  56. Malvasi A, Cavallotti C, Nicolardi G, Pellegrino M, Dell'Edera D, Vergara D, et al. NT, NPY and PGP 9.5 presence in myometrium and in fibroid pseudocapsule and their possible impact on muscular physiology. Gynecol Endocrinol. 2013;29:177–81.

    Article  PubMed  Google Scholar 

  57. Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011;17:772–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998;13:1968–74.

    Article  CAS  PubMed  Google Scholar 

  59. Yoshino O, Nishii O, Osuga Y, Asada H, Okuda S, Orisaka M, et al. Myomectomy decreases abnormal uterine peristalsis and increases pregnancy rate. J Minim Invasive Gynecol. 2012;19:63–7.

    Article  PubMed  Google Scholar 

  60. Campo S, Campo V, Gambadauro P. Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas. Eur J Obstet Gynecol Reprod Biol. 2003;110:215–9.

    Article  PubMed  Google Scholar 

  61. Bulletti C, DE Ziegler D, Levi Setti P, Cicinelli E, Polli V, Stefanetti M. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci. 2004;1034:84–92.

    Article  PubMed  Google Scholar 

  62. Chang WC, Chu LH, Huang PS, Huang SC, Sheu BC. Comparison of laparoscopic myomectomy in large myomas with and without leuprolide acetate. J Minim Invasive Gynecol. 2015;22:992–6.

    Article  PubMed  Google Scholar 

  63. Lavazzo C, Mamais I, Gkegkes ID. Use of misoprostol in myomectomy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2015;292:1185–91.

    Article  Google Scholar 

  64. Abdel-Hafeez M, Elnaggar A, Ali M, Ismail AM, Yacoub M. Rectal misoprostol for myomectomy: a randomized placebo-controlled study. Aust N Z J Obstet Gynaecol. 2015;55:363–8.

    Article  PubMed  Google Scholar 

  65. Tsuji S, Takahashi K, Imaoka I, Sugimura K, Miyazaki K, Noda Y. MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Investig. 2006;61:106–10.

    Article  Google Scholar 

  66. Landon MB, Lynch CD. Optimal timing and mode of delivery after cesarean with previous classical incision or myomectomy: a review of the data. Semin Perinatol. 2011;35:257–61.

    Article  PubMed  Google Scholar 

  67. Pluchino N, Litta P, Freschi L, Russo M, Simi G, Santoro AN, et al. Comparison of the initial surgical experience with robotic and laparoscopic myomectomy. Int J Med Robot. 2014;10:208–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Infertility and Reproductive Surgery, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA

    Paula C. Brady MD & Antonio R. Gargiulo MD

Authors
  1. Paula C. Brady MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio R. Gargiulo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio R. Gargiulo MD .

Editor information

Editors and Affiliations

  1. Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, University of Florida, Gainesville, Florida, USA

    Nash S. Moawad

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Brady, P.C., Gargiulo, A.R. (2018). Large Asymptomatic FIGO Type 3–5 Fibroid and Primary Infertility. In: Moawad, N. (eds) Uterine Fibroids. Springer, Cham. https://doi.org/10.1007/978-3-319-58780-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58780-6_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58779-0

  • Online ISBN: 978-3-319-58780-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation